Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Some breast cancer chemotherapy can cause permanent hair loss.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Accurate diagnosis and treatment are crucial for managing superficial fungal infections, with terbinafine being the best oral treatment for nail infections.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.